Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANL compared with BBOT: revenue, margins and what each company keeps, and the suppliers and customers both name
ANL
Adlai Nortye Ltd.
Change
Mkt cap
Revenue
Revenue
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANL
Adlai Nortye Ltd.
vs
BBOT
BridgeBio Oncology Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ANL: latest quarter not drawable. BBOT: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ANL
0
None
Shared
0
No disclosed counterparties: ANL.
Only BBOT
2
LDOS
Leidos Biomedical Research
supplier
—
Lawrence Livermore National Security, LLC (LLNS)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANL, solid
BBOT, dashed
ANL
Adlai Nortye Ltd.
Change
9.36
▼
−2.32%
· post 9.36
· delayed
Mkt cap
$918.9M
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
2.31
▼
−0.64%
· post 2.31
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$185.7M
vs
Compare
After hours
Nov 4 '26
delayed
ANL
Adlai Nortye Ltd.
vs
BBOT
BridgeBio Oncology Therapeutics, Inc.
9.36
▼
−2.32%
post 9.36
delayed
Price
2.31
▼
−0.64%
post 2.31
delayed
$918.9M
Mkt cap
$185.7M
Change
Change
ANL
9.36
▼
−2.32%
vs
BBOT
2.31
▼
−0.64%
After hours
Nov 4 '26
delayed